MRKR MARKER THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - Other Events Marker Therapeutics announces preliminary results for Phase 1 clinical trial of MT-601.Get access to all SEC 8-K filings of the MARKER THERAPEUTICS INC